Case Study
Scaling Smart: Readiness Delivered at a Biotech Inflection Point
A late-stage clinical biopharma firm was preparing for its first U.S. commercial launch and European expansion. With external spend expected to double from $125M to $250M+ in a year, the company needed to rapidly transform procurement from reactive and manual to strategic and future-ready - without overbuilding or slowing growth.
Normal for this company stage, Procurement was decentralized, policy-light, and reliant on legacy vendor relationships. Stakeholders lacked clarity on procurement’s role, and leadership needed confidence that procurement could scale the supply base and performance with the business while managing risk, cost, and compliance in a high-growth environment.
We executed a six-week strategic readiness diagnostic that:
A procurement strategy and roadmap aligned to $250M+ in forecasted spend
Enabled executive buy-in of a new procurement mandate – strategic, not tactical
Spend consolidation and supplier governance actions sequenced for self-funding function build and early wins
Positioned procurement as a force-multiplier for growth – lean, agile, and built to scale without waste
